Home
Novo Holdings A/S reported a 6.5% stake in Damora Therapeutics DMRA · 86,579 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 6.5%
- Last report
- 7.6% · filed 25/01/16
- Shares held
- 86,579 sh
- Class
- Common Stock, par value $0.00001 per share
- Holder
- Novo Holdings A/S
- Event date
- 25/09/23
- Filed
- 25/09/25
6.5% stake · −1.1pp from the last report
- Stake
- 6.5%
- Last report
- 7.6%
- Since last report
- −1.1pp
Damora Therapeutics trades, last 26 weeks
What else happened in Damora Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/24~25/10/23Novo Holdings A/S's other 5% stake reports
- Novo Holdings A/S
5% stakeHemab Therapeutics Holdings
5% stakeHemab Therapeutics Holdings
COAG
9% stake
4,180,550 sh
9% stake
Filed 08/14
- Novo Holdings A/S
5% stakeAvalyn Pharma
5% stakeAvalyn Pharma
AVLN
8.8% stake
3,883,289 sh
8.8% stake
Filed 08/14
- Novo Holdings A/S
5% stakeObsidian Therapeutics
5% stakeObsidian Therapeutics
OBX
5.1% stake
3,123,992 sh
5.1% stake
Filed 08/10
- Novo Holdings A/S
5% stakeMapLight Therapeutics
5% stakeMapLight Therapeutics
MPLT
4.9% stake
2,086,622 sh
4.9% stake
Filed 07/31
- Novo Holdings A/S
5% stakeEdgewise Therapeutics
5% stakeEdgewise Therapeutics
EWTX
4.9% stake
5,350,000 sh
4.9% stake
Filed 04/27
